论文部分内容阅读
目的分析医院抗口服消化性溃疡药的使用情况,为临床合理用药提供参考。方法回顾性统计分析2012-2014年医院口服抗消化性溃疡药的销售金额、用药频度(DDDs)及限定日费用(DDDc)等情况。结果医院抗消化性溃疡药的使用量逐年增长;质子泵抑制剂(PPI)连续3年位居销售金额和DDDs的榜首,且占比也稳步提升。结论医院口服抗消化性溃疡药临床应用较合理,PPI已成为医院治疗消化性溃疡(PU)的首选药,医院抗消化性溃疡药的应用与国内报道的用药情况基本相符。
Objective To analyze the use of anti-oral peptic ulcer drugs in hospitals to provide reference for clinical rational drug use. Methods Retrospective statistical analysis was conducted on the sales amount, frequency of medication (DDDs) and DDDc of oral anti-peptic ulcer drugs from 2012 to 2014 in hospitals. Results Hospital anti-peptic ulcer drug use increased year by year; proton pump inhibitor (PPI) for three consecutive years ranked first in sales volume and DDDs, and the proportion also steadily increased. Conclusion The clinical application of oral anti-peptic ulcer medicine in the hospital is reasonable. PPI has become the first choice of hospital for the treatment of peptic ulcer (PU). The application of anti-peptic ulcer medicine in hospital is basically consistent with that reported in the country.